Vaccine industry executives are publicly blaming U.S. Health Secretary Robert F. Kennedy Jr. for tanking stock prices, declining vaccine sales in the U.S. and their reluctance to invest in clinical trials for new vaccines. Asked what would need to change to move vaccine discussions forward, Pfizer CEO Albert Bourla answered: “The secretary of health,” The Wall Street Journal reported […]